1. Home
  2. BANC vs BEAM Comparison

BANC vs BEAM Comparison

Compare BANC & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banc of California Inc.

BANC

Banc of California Inc.

HOLD

Current Price

$18.76

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$24.16

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BANC
BEAM
Founded
1941
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BANC
BEAM
Price
$18.76
$24.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
12
Target Price
$19.28
$48.09
AVG Volume (30 Days)
2.2M
2.2M
Earning Date
10-22-2025
11-04-2025
Dividend Yield
2.14%
N/A
EPS Growth
N/A
N/A
EPS
1.03
N/A
Revenue
$1,019,965,000.00
$55,701,000.00
Revenue This Year
$8.50
N/A
Revenue Next Year
$12.76
$19.01
P/E Ratio
$18.21
N/A
Revenue Growth
147.22
N/A
52 Week Low
$11.52
$13.53
52 Week High
$18.83
$35.25

Technical Indicators

Market Signals
Indicator
BANC
BEAM
Relative Strength Index (RSI) 68.44 52.36
Support Level $18.37 $20.23
Resistance Level $18.71 $25.56
Average True Range (ATR) 0.51 1.61
MACD 0.19 0.41
Stochastic Oscillator 99.45 72.11

Price Performance

Historical Comparison
BANC
BEAM

About BANC Banc of California Inc.

Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: